Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing heparin flushes to lepirudin flushes to prevent blockage of venous access devices in patients at risk of thrombosis; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Heparin (unfractionated heparin)
  • Lepirudin (lepirudin)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Thrombosis | Phase 2 | Status: COMPLETED